Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$404,464
-$3,565,730 QoQ
Shares Held
1,872
-91.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#606
of 1,031 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SummitTX Capital, L.P. holds $15,756,921 across 8 Drug Manufacturers - General names. BIIB ranks #7 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
41,589 | $5,254,354 | |
| 2 | LLY |
ELI LILLY & Co
|
2,362 | $2,833,053 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
44,239 | $2,549,051 | |
| 4 | PFE |
Pfizer Inc
|
103,387 | $2,489,558 | |
| 5 | ABBV |
AbbVie Inc.
|
3,743 | $941,888 | |
| 6 | JNJ |
Johnson & Johnson
|
3,540 | $899,053 | |
| 7 | BIIB |
Biogen Inc.
This page
|
1,872 | $404,464 | |
| 8 | MRK |
Merck & Co., Inc.
|
3,000 | $385,500 |
All Filings in BIIB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $404,464 | 1,872 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,970,194 | 21,656 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $2,434,450 | 17,379 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $6,903,682 | 54,970 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,598,564 | 11,682 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||